未登录

P

Patrizia Leone

Department of Interdisciplinary Medicine

H指数:16

被引数:1,281

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Editorial: Autoimmune diseases: from molecular mechanisms to therapy development

社论：自身免疫性疾病：从分子机制到疗法开发

Frontiers in Immunology

IF5.9

2026-01-060

OAAI

SARS-CoV-2-Specific CD8+ T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection

感染后接种疫苗的K18-hACE2小鼠血液中SARS-CoV-2-Specific的CD8 T细胞，但肺部没有

IF3.4

2023-08-301

OAAI

Antiviral effect of SARS-CoV-2 N-specific CD8+ T cells induced in lungs by engineered extracellular vesicles

IF6.5

2023-06-027

OAAI

Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein

用N病毒蛋白工程改造的细胞外囊泡激活Anti-SARS-CoV-2人ctl

IF3.4

2022-06-304

OAAI

Strong SARS-CoV-2 N-Specific CD8+ T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in Mice

IF3.5

2022-02-0619

OAAI

The C-Terminal Domain of Nefmut Is Dispensable for the CD8+ T Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles

IF3.4

2021-04-125

OAAI

Simultaneous CD8+ T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs

脾脏和肺脏中内源性工程细胞外囊泡诱导的针对SARS-Cov-2 S，M和N的同时CD8 T细胞免疫反应

IF3.4

2021-03-1018

OAAI

Engineered Extracellular Vesicles/Exosomes as a New Tool against Neurodegenerative Diseases

IF5.5

2020-06-0911

OAAI

N-Terminal Fatty Acids of NEFMUTAre Required for the CD8+T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles

IF3.4

2020-05-2212

OAAI

The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells

INTERNATIONAL JOURNAL OF NANOMEDICINE

IF6.5

2019-11-0120

OAAI

Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity

IF3.1

2012-05-1533

OAAI

Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome-independent block of angiogenesis and matrix metalloproteinases

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2010-10-2744

OAAI

Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir

IF3.1

2009-02-2028

OAAI

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma

NATURE MEDICINE

IF50

2002-03-01291

PREAI

Clearance of human herpesvirus 8 from blood and regression of leukopenia-associated aggressive classic Kaposi's sarcoma during interferon-α therapy:: A case report

CLINICAL INFECTIOUS DISEASES

IF7.3

2001-11-157

OAAI

Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients

JOURNAL OF INFECTION

IF11.9

2001-10-0187

PREAI

Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor

MOLECULAR BIOLOGY OF THE CELL

IF2.7

2001-10-0188

OAAI

Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells

JOURNAL OF VIROLOGY

IF3.8

1999-05-0175

OA